Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
78,47 USD | -2,45 % |
|
+1,02 % | +12,78 % |
Métier
- vente de médicaments génériques (79,9%) : médicaments de prescription de marque ou sans marque et médicaments OTC ;
- vente d'ingrédients actifs (15,7%). Par ailleurs, le groupe propose des prestations de services pharmaceutiques personnalisés ;
- autres (4,4%) : vente de produits biopharmaceutiques génériques, développement d'agents moléculaires, etc.
La répartition géographique du CA est la suivante : Inde (18,8%), Etats-Unis (45%), Russie (9,9%) et autres (26,3%).
Nombre d'employés: 27 048
Ventes par activité
INR en Millions | 2023 | Poids | 2024 | Poids | Delta |
---|---|---|---|---|---|
Global Generics
87,9
%
| 213 768 | 86,9 % | 245 453 | 87,9 % | +14,82 % |
Pharmaceutical Services and Active Ingredients
10,7
%
| 29 069 | 11,8 % | 29 801 | 10,7 % | +2,52 % |
Others
1,4
%
| 3 042 | 1,2 % | 3 910 | 1,4 % | +28,53 % |
Ventes par région
INR en Millions | 2023 | Poids | 2024 | Poids | Delta |
---|---|---|---|---|---|
United States
48,6
%
| 106 683 | 43,4 % | 135 565 | 48,6 % | +27,07 % |
Others
26,1
%
| 67 469 | 27,4 % | 72 825 | 26,1 % | +7,94 % |
India
17,4
%
| 50 499 | 20,5 % | 48 473 | 17,4 % | -4,01 % |
Russia
8,0
%
| 21 228 | 8,6 % | 22 301 | 8,0 % | +5,05 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 02/04/18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 02/11/20 |
Chairman | 56 | 18/01/93 | |
Gunupati Prasad
CHM | Chairman | 63 | 08/04/86 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/23 |
K. Randhir Singh
CMP | Compliance Officer | - | 17/03/22 |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 01/05/21 |
Deepak Sapra
PRN | Corporate Officer/Principal | - | 01/01/03 |
Archana Bhaskar
HRO | Human Resources Officer | 57 | 01/06/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 08/04/86 |
Chairman | 56 | 18/01/93 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 05/06/07 |
Shikha Sharma
BRD | Director/Board Member | 64 | 31/01/19 |
Leo Puri
BRD | Director/Board Member | 63 | 25/10/18 |
Claudio Albrecht
BRD | Director/Board Member | 64 | 10/05/23 |
Arun M. Kumar
BRD | Director/Board Member | 72 | 01/08/22 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | 29/12 |
Director/Board Member | 64 | 07/01/22 | |
Alpna Seth
BRD | Director/Board Member | 60 | 19/09/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 166 829 701 | 117 879 796 ( 70,66 %) | 289 791 ( 0,1737 %) | 70,66 % |
Coordonnées société
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.com![Adresse Dr. Reddy's Laboratories Limited(RDY)](https://cdn.zonebourse.com/static/address/14214.png)
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Dr. Reddy's Laboratories SA
![]() Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Aurigene Pharmaceutical Services Ltd.
![]() Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Secteur
Ventes par activité
Ventes par région
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+61,53 % | 848 Md | |
+38,95 % | 627 Md | |
-3,66 % | 363 Md | |
+15,06 % | 318 Md | |
+9,18 % | 299 Md | |
+5,89 % | 234 Md | |
+16,53 % | 225 Md | |
+15,67 % | 179 Md | |
+2,47 % | 167 Md |
- Bourse
- Actions
- Action DRREDDY
- Action RDY
- Société Dr. Reddy's Laboratories Limited